News

The Private Placement Financing was taken out for gross proceeds of €10.3 million, €8 million via convertible bonds (of which €4 million were received in December 2019). Affluent Medical has [...]

Epygon is the first transcatheter mitral valve designed to restore the physiological blood flow vortex and treat left ventricle disease, in particular in so-called “functional” patients. No mitral valve prosthesis [...]

KALIOS is the first fully adjustable mitral valve repair ring, designated for the percutaneous treatment of both residual and recurrent Mitral Regurgitation (MR). First patient implanted in Vienna General Hospital [...]

Michel Finance is appointed CEO. Executive team is strengthened with the appointment of: Daniele Zanotti (the former CEO) as Chief Technology and Innovation Officer leading technology developments and the execution [...]